Opinion|Videos|January 31, 2025
Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas
Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease and when modifications might be necessary as well as the incorporation of infection prevention strategies, including prophylactic antimicrobials, into management plans.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do step-up dosing protocols reduce CRS risk in patients with high-risk disease, and when might you modify this approach? (Dr Allan)
- How do you incorporate infection prevention strategies, such as prophylactic antimicrobials, into your management plans? (Dr Graff)
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
5